School of Medicine
Showing 31-40 of 46 Results
-
Gaurav Parmar, MD, MPH
Clinical Assistant Professor, Surgery - Vascular Surgery
Current Research and Scholarly InterestsMy research focuses on improving the diagnosis, treatment, and prevention of vascular disease through clinical and translational investigation. Areas of interest include arterial and venous thrombosis, thoracic aortic disease, peripheral artery disease, vascular imaging, and implementation of evidence-based care models. I am particularly interested in multidisciplinary vascular care, clinical trials, outcomes research, and reducing cardiovascular disparities.
-
Laura Petrikovic, PA-C
Affiliate, Surgery - Vascular Surgery
BioLead advanced practice provider (APP) for the Vascular Surgery division of CVH at Stanford Palo Alto campus. Experienced advanced practice provider (APP) with broad medical knowledge, including prior roles in Neurosurgery and Cardiovascular Surgery. Moved to California from Pennsylvania and began working for Stanford Vascular Surgery in April 2021. Previous affiliation with UPMC in Pittsburgh, PA.
-
Eric Brian Pillado
Clinical Assistant Professor, Surgery - Vascular Surgery
BioDr. Pillado earned his bachelor’s degree at the University of Michigan before completing his medical degree at the University of California, Los Angeles. He then completed his vascular surgery residency at Northwestern University, where he also obtained a Master of Science in Health Services and Outcomes Research as well as a Master of Business Administration from the Kellogg School of Management during his professional development time.
His clinical research interests include improving vascular surgery healthcare delivery systems in underserved patient populations, multidisciplinary limb salvage, and advancing wellness initiatives within vascular surgery training. -
Nazish Sayed MD, PhD
Associate Professor (Research) of Surgery (Vascular Surgery)
Current Research and Scholarly InterestsThe Sayed Laboratory investigates how endothelial dysfunction contributes to cardiovascular disease and leverages human stem cell technologies to identify novel therapeutic strategies. Our research integrates patient-derived induced pluripotent stem cells (iPSCs), engineered cardiac tissues, organoids, human biospecimens, and multi-omic technologies to uncover mechanisms underlying inherited and acquired cardiovascular diseases.
A major focus of the laboratory is understanding endothelial–cardiomyocyte communication in cardiomyopathy. Using patient-specific iPSCs, human cardiac organoids, engineered heart tissues, spatial transcriptomics, and single-cell multi-omics, we study how endothelial dysfunction drives myocardial fibrosis, inflammation, and heart failure. Current efforts include investigations into LMNA-related dilated cardiomyopathy, endothelial-to-mesenchymal transition (EndoMT), and mechanisms of fibrotic remodeling.
A second major area of research is cardio-oncology. The laboratory develops human disease models to understand cardiovascular complications associated with cancer therapies, including tyrosine kinase inhibitors and immune checkpoint inhibitors. These studies have identified novel vascular mechanisms underlying treatment-related hypertension, cardiomyopathy, and heart failure.
The laboratory also investigates cardiovascular aging, toxic environmental exposures, rare vascular diseases, and regenerative medicine. By integrating human tissues, advanced stem cell models, genome engineering, spatial biology, and artificial intelligence–enabled multi-omic analyses, our goal is to develop precision therapeutic strategies that improve cardiovascular health and patient outcomes.
